Prism Medico & Pharmacy Ltd Fair Value
PRISMMEDI · Financial Services · Current price ₹30
| Method | Fair value | Status |
|---|---|---|
| Excess-return (book value) | ₹14 | 0% ROE fading to 13% over ~3 yrs, on ₹17 book |
| Relative P/E | — | Needs positive EPS |
| Graham floor | — | Not meaningful for financials |
| Analyst target | — | No analyst coverage |
Is Prism Medico & Pharmacy Ltd undervalued?
DocStoX estimates the fair value of Prism Medico & Pharmacy Ltd at ₹14 per share, versus the current market price of ₹30. That puts the stock about -53.3% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 1 independent method: Excess-return (book value) (₹14). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹12 (bear) to ₹14 (base) to ₹16 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on Prism Medico & Pharmacy Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.